President Donald J. Trump has signed an Executive Order to fill the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) with key drug components. The move is intended to strengthen the domestic supply chain for essential medicines.
The administration stated that increasing the capacity for domestic production of vital pharmaceutical products is important for protecting national health and security from global supply chain disruptions.
The White House emphasized President Trump's ongoing focus on policies aimed at securing pharmaceutical independence for the United States and maintaining access to affordable, domestically produced drugs.
"Restoring capacity for domestic production of essential pharmaceutical products is essential to safeguarding national health and security against global supply chain disruptions."
"President Trump has consistently prioritized policies to secure America’s pharmaceutical independence and ensure access to affordable, domestically produced drugs."
